ProShare Advisors LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$76,000
-23.2%
15,568
-1.7%
0.00%0.0%
Q2 2018$99,000
-28.3%
15,833
-4.5%
0.00%0.0%
Q1 2018$138,000
-29.9%
16,571
-14.1%
0.00%0.0%
Q4 2017$197,000
+159.2%
19,295
+67.9%
0.00%0.0%
Q3 2016$76,000
-39.7%
11,490
-15.7%
0.00%
-50.0%
Q2 2016$126,000
-6.0%
13,622
+10.0%
0.00%0.0%
Q1 2016$134,000
-31.3%
12,389
-9.1%
0.00%0.0%
Q4 2015$195,00013,6230.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Sio Capital Management, LLC 666,729$14,008,0009.60%
DSC Advisors, L.P. 907,358$17,157,0008.33%
DAFNA Capital Management LLC 63,400$1,332,0001.32%
WALL STREET ASSOCIATES 199,343$4,188,0000.80%
Perceptive Advisors 742,132$15,592,0000.62%
EMERALD MUTUAL FUND ADVISERS TRUST 331,142$6,957,0000.46%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 458,332$9,630,0000.37%
EMERALD ADVISERS, LLC 321,313$6,751,0000.35%
Tourbillon Capital Partners, L.P. 611,686$12,852,0000.34%
DSC Advisors, L.P. 31,240$656,0000.32%
View complete list of NEOS THERAPEUTICS INC shareholders